糖尿病中的“硬”终点、“软”终点及“替代”终点 - Suppr

Suppr

超能文献

'Hard,' 'soft' and 'surrogate' endpoints in diabetes.

作者信息

Yudkin John S, Eggleston Emma M

出版信息

J Epidemiol Community Health. 2013 Apr;67(4):295-7. doi: 10.1136/jech-2012-201361. Epub 2012 Nov 21.

DOI:10.1136/jech-2012-201361

PMID:23172608

Abstract

摘要

相似文献

'Hard,' 'soft' and 'surrogate' endpoints in diabetes.

J Epidemiol Community Health. 2013 Apr;67(4):295-7. doi: 10.1136/jech-2012-201361. Epub 2012 Nov 21.

The benefits of tight control. No end in sight.

Diabetes Self Manag. 2006 May-Jun;23(3):29-30, 33-4.

Diabetes: glycated hemoglobin is a marker of diabetes and CVD risk.

Nat Rev Cardiol. 2010 Jul;7(7):367-8. doi: 10.1038/nrcardio.2010.84.

[Lowering blood glucose has little effect: myth or fact?].

MMW Fortschr Med. 2015 Nov 19;157(20):14.

[Diabetic complications: good metabolic control protects].

MMW Fortschr Med. 2011 Apr 14;153(15):44-5.

[Typ 2 diabetes: glucose centered therapy is obsolete].

MMW Fortschr Med. 2008 May 1;150(18):26-7. doi: 10.1007/BF03372044.

Does the American Diabetes Association recommend using the hemoglobin A1c test to diagnose diabetes?

J Am Diet Assoc. 2010 Mar;110(3):484. doi: 10.1016/j.jada.2010.01.006.

[Diabetes mellitus--diagnosis and blood glucose control].

Praxis (Bern 1994). 2008 May 14;97(10):529-37; quiz 538-9. doi: 10.1024/1661-8157.97.10.529.

New guidelines promote nonfasting blood test for diabetes diagnosis.

Mayo Clin Womens Healthsource. 2010 Jun;14(6):3.

Intensified glucose control in type 2 diabetes--whose agenda?

Lancet. 2011 Apr 9;377(9773):1220-2. doi: 10.1016/S0140-6736(10)61112-9. Epub 2010 Nov 18.

引用本文的文献

Need for better reporting of trials with surrogate endpoints: SPIRIT|CONSORT-SURROGATE extensions.

J Epidemiol Community Health. 2022 Jun 24;76(9):769-70. doi: 10.1136/jech-2022-219294.

Is HbA1c a valid surrogate for mortality in type 2 diabetes? Evidence from a meta-analysis of randomized trials.

Acta Diabetol. 2022 Oct;59(10):1257-1263. doi: 10.1007/s00592-022-01887-y. Epub 2022 May 9.

Glycemic Control for Patients With Type 2 Diabetes Mellitus: Our Evolving Faith in the Face of Evidence.

Circ Cardiovasc Qual Outcomes. 2016 Sep;9(5):504-12. doi: 10.1161/CIRCOUTCOMES.116.002901. Epub 2016 Aug 23.

Inequalities in health care among patients with type 2 diabetes by individual socio-economic status (SES) and regional deprivation: a systematic literature review.

Int J Equity Health. 2014 Jun 2;13:43. doi: 10.1186/1475-9276-13-43.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

'Hard,' 'soft' and 'surrogate' endpoints in diabetes.

J Epidemiol Community Health. 2013 Apr;67(4):295-7. doi: 10.1136/jech-2012-201361. Epub 2012 Nov 21.

The benefits of tight control. No end in sight.

Diabetes Self Manag. 2006 May-Jun;23(3):29-30, 33-4.

Diabetes: glycated hemoglobin is a marker of diabetes and CVD risk.

Nat Rev Cardiol. 2010 Jul;7(7):367-8. doi: 10.1038/nrcardio.2010.84.

[Lowering blood glucose has little effect: myth or fact?].

MMW Fortschr Med. 2015 Nov 19;157(20):14.

[Diabetic complications: good metabolic control protects].

MMW Fortschr Med. 2011 Apr 14;153(15):44-5.

[Typ 2 diabetes: glucose centered therapy is obsolete].

MMW Fortschr Med. 2008 May 1;150(18):26-7. doi: 10.1007/BF03372044.

Does the American Diabetes Association recommend using the hemoglobin A1c test to diagnose diabetes?

J Am Diet Assoc. 2010 Mar;110(3):484. doi: 10.1016/j.jada.2010.01.006.

[Diabetes mellitus--diagnosis and blood glucose control].

Praxis (Bern 1994). 2008 May 14;97(10):529-37; quiz 538-9. doi: 10.1024/1661-8157.97.10.529.

New guidelines promote nonfasting blood test for diabetes diagnosis.

Mayo Clin Womens Healthsource. 2010 Jun;14(6):3.

Intensified glucose control in type 2 diabetes--whose agenda?

Lancet. 2011 Apr 9;377(9773):1220-2. doi: 10.1016/S0140-6736(10)61112-9. Epub 2010 Nov 18.

引用本文的文献

Need for better reporting of trials with surrogate endpoints: SPIRIT|CONSORT-SURROGATE extensions.

J Epidemiol Community Health. 2022 Jun 24;76(9):769-70. doi: 10.1136/jech-2022-219294.

Is HbA1c a valid surrogate for mortality in type 2 diabetes? Evidence from a meta-analysis of randomized trials.

Acta Diabetol. 2022 Oct;59(10):1257-1263. doi: 10.1007/s00592-022-01887-y. Epub 2022 May 9.

Glycemic Control for Patients With Type 2 Diabetes Mellitus: Our Evolving Faith in the Face of Evidence.

Circ Cardiovasc Qual Outcomes. 2016 Sep;9(5):504-12. doi: 10.1161/CIRCOUTCOMES.116.002901. Epub 2016 Aug 23.

Inequalities in health care among patients with type 2 diabetes by individual socio-economic status (SES) and regional deprivation: a systematic literature review.

Int J Equity Health. 2014 Jun 2;13:43. doi: 10.1186/1475-9276-13-43.